Richard Afriyie Osei

The Cancer Organoid Digital Twin: A Critical Review of AI-Enabled Patient-Specific Modeling of Drug Response, Resistance, and Tumor Evolution

Richard Afriyie Osei, Olaitan Ebenezer Oluwadare & Olatunde Simeon Awolola · International Research Journal of Oncology · 2026

The integration of patient-derived cancer organoids with artificial intelligence (AI) offers a potential approach for developing more individualised models of tumour behaviour and therapeutic response. Conventional precision oncology relies heavily on static molecular measurement...

Open access Research Article 10.9734/irjo/2026/v9i2234

Extended Half-life Versus Standard Half-life Factor Replacement Therapy in Hemophilia A and B: A Systematic Review and Meta-analysis

Kwesi Akonu Adom Mensah Forson, Obiageri Ihuarulam Okeoma, Oluchi Okechukwu, Chidinma Lorretta Gab-Obinna, Enobong Edoabasi Obong, Richard Afriyie Osei & Jazuli Isyaku Bala · International Journal of Research and Reports in Hematology · 2026

Hemophilia is a congenital bleeding disorder that requires frequent factor replacement therapies to manage bleeding episodes. This systematic review and meta-analysis compares the efficacy of extended half-life (EHL) and standard half-life (SHL) factor replacement therapies in pa...

Open access Research Article 10.9734/ijr2h/2026/v9i1215